STOCK TITAN

[425] Sonnet BioTherapeutics Holdings, Inc. Business Combination Communication

(High)
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Analyzing...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

Filed by Sonnet BioTherapeutics Holdings, Inc.

pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

 

Subject Company: Sonnet BioTherapeutics Holdings, Inc.

Commission File No. 001-35570

 

Date: November 18, 2025